BioCentury
ARTICLE | Financial News

Cancer Prevention Pharmaceuticals withdraws IPO

November 4, 2016 8:41 PM UTC

Cancer Prevention withdrew its IPO on NYSE MKT, citing market conditions. Last December, it filed to raise up to $28.8 million....